This ADC product is comprised of an a Epratuzumab conjugated via a CL2A linker to a SN-38.The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis.The SN-38 is targeted to certain canc
When you call, don't forget to mention that you found this ad on I do not wish to be contacted by telemarketers or representatives of any other website.